Prostaglandin D2 stimulates phenotypic changes in vascular smooth muscle cells View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2019-11-18

AUTHORS

Hye Sun Lee, Sung Ji Yun, Jung Min Ha, Seo Yeon Jin, Hong Koo Ha, Sang Heon Song, Chi Dae Kim, Sun Sik Bae

ABSTRACT

Since chronic inflammation is associated with the pathogenesis of atherosclerosis, inflammatory cytokines might contribute to the phenotypic modulation of vascular smooth muscle cells (VSMCs). Tumor necrosis factor α (TNFα) facilitated the transformation of contractile VSMCs to the synthetic phenotype, as determined by the expression of marker proteins and a collagen gel contraction assay. Western blot analysis and a cyclooxygenase-2 (COX2) promoter assay revealed that TNFα stimulation resulted in the induction of COX2. The overexpression, silencing, or pharmacological inhibition of COX2 significantly affected TNFα-induced phenotypic conversion, and of the tested prostaglandins, only PGD2 significantly induced phenotypic conversion. ERK was significantly activated by PGD2 stimulation, and the pharmacological inhibition of ERK blocked the PGD2-induced phenotypic conversion of VSMCs. However, antagonists or agonists of PGD2 receptors did not affect VSMC conversion. In contrast, spontaneously dehydrated forms of PGD2, such as PGJ2, Δ12-PGJ2, and 15-d-PGJ2, strongly induced phenotypic conversion. A reporter gene assay showed that TNFα, PGD2, and 15-d-PGJ2 significantly activated the peroxisome proliferator-responsive element (PPRE) promoter. In addition, the overexpression or silencing of peroxisome proliferator-activated receptor δ (PPARδ) significantly influenced 15-d-PGJ2-induced phenotypic conversion. Finally, atherosclerotic neointima formation was significantly suppressed in mice lacking TNFα. In addition, mice fed celecoxib exhibited complete inhibition of carotid artery ligation-induced neointima formation. This study shows that PGD2 regulates the phenotypic conversion of VSMCs by generating an endogenous ligand of PPAR, and that this leads to neointima formation in occlusive arterial disease. More... »

PAGES

1-10

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/s12276-019-0330-3

DOI

http://dx.doi.org/10.1038/s12276-019-0330-3

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1122663772

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/31735914


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/03", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Chemical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0304", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medicinal and Biomolecular Chemistry", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blotting, Western", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cells, Cultured", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cyclooxygenase 2", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunohistochemistry", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lentivirus", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice, Mutant Strains", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Muscle, Smooth, Vascular", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Myocytes, Smooth Muscle", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "PPAR gamma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Phenotype", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prostaglandin D2", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rats", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rats, Sprague-Dawley", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Signal Transduction", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tumor Necrosis Factor-alpha", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Gene and Cell Therapy Center for Vessel-Associated Disease, Medical Research Institute, and Department of Pharmacology, Pusan National University School of Medicine, 50612, Gyungnam, Republic of Korea", 
          "id": "http://www.grid.ac/institutes/grid.262229.f", 
          "name": [
            "Gene and Cell Therapy Center for Vessel-Associated Disease, Medical Research Institute, and Department of Pharmacology, Pusan National University School of Medicine, 50612, Gyungnam, Republic of Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lee", 
        "givenName": "Hye Sun", 
        "id": "sg:person.0725005515.87", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0725005515.87"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Gene and Cell Therapy Center for Vessel-Associated Disease, Medical Research Institute, and Department of Pharmacology, Pusan National University School of Medicine, 50612, Gyungnam, Republic of Korea", 
          "id": "http://www.grid.ac/institutes/grid.262229.f", 
          "name": [
            "Gene and Cell Therapy Center for Vessel-Associated Disease, Medical Research Institute, and Department of Pharmacology, Pusan National University School of Medicine, 50612, Gyungnam, Republic of Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yun", 
        "givenName": "Sung Ji", 
        "id": "sg:person.0713276127.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0713276127.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Gene and Cell Therapy Center for Vessel-Associated Disease, Medical Research Institute, and Department of Pharmacology, Pusan National University School of Medicine, 50612, Gyungnam, Republic of Korea", 
          "id": "http://www.grid.ac/institutes/grid.262229.f", 
          "name": [
            "Gene and Cell Therapy Center for Vessel-Associated Disease, Medical Research Institute, and Department of Pharmacology, Pusan National University School of Medicine, 50612, Gyungnam, Republic of Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ha", 
        "givenName": "Jung Min", 
        "id": "sg:person.01372533376.74", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01372533376.74"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Gene and Cell Therapy Center for Vessel-Associated Disease, Medical Research Institute, and Department of Pharmacology, Pusan National University School of Medicine, 50612, Gyungnam, Republic of Korea", 
          "id": "http://www.grid.ac/institutes/grid.262229.f", 
          "name": [
            "Gene and Cell Therapy Center for Vessel-Associated Disease, Medical Research Institute, and Department of Pharmacology, Pusan National University School of Medicine, 50612, Gyungnam, Republic of Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jin", 
        "givenName": "Seo Yeon", 
        "id": "sg:person.01324754010.02", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01324754010.02"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Urology, Pusan National University Hospital, 49241, Busan, Republic of Korea", 
          "id": "http://www.grid.ac/institutes/grid.412588.2", 
          "name": [
            "Department of Urology, Pusan National University Hospital, 49241, Busan, Republic of Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ha", 
        "givenName": "Hong Koo", 
        "id": "sg:person.0712676025.34", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0712676025.34"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Pusan National University Hospital, 49241, Busan, Republic of Korea", 
          "id": "http://www.grid.ac/institutes/grid.412588.2", 
          "name": [
            "Department of Internal Medicine, Pusan National University Hospital, 49241, Busan, Republic of Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Song", 
        "givenName": "Sang Heon", 
        "id": "sg:person.01032567265.78", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01032567265.78"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Gene and Cell Therapy Center for Vessel-Associated Disease, Medical Research Institute, and Department of Pharmacology, Pusan National University School of Medicine, 50612, Gyungnam, Republic of Korea", 
          "id": "http://www.grid.ac/institutes/grid.262229.f", 
          "name": [
            "Gene and Cell Therapy Center for Vessel-Associated Disease, Medical Research Institute, and Department of Pharmacology, Pusan National University School of Medicine, 50612, Gyungnam, Republic of Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kim", 
        "givenName": "Chi Dae", 
        "id": "sg:person.015416324124.64", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015416324124.64"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Gene and Cell Therapy Center for Vessel-Associated Disease, Medical Research Institute, and Department of Pharmacology, Pusan National University School of Medicine, 50612, Gyungnam, Republic of Korea", 
          "id": "http://www.grid.ac/institutes/grid.262229.f", 
          "name": [
            "Gene and Cell Therapy Center for Vessel-Associated Disease, Medical Research Institute, and Department of Pharmacology, Pusan National University School of Medicine, 50612, Gyungnam, Republic of Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bae", 
        "givenName": "Sun Sik", 
        "id": "sg:person.01113214531.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01113214531.31"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/358771a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007692609", 
          "https://doi.org/10.1038/358771a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nature01323", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001371417", 
          "https://doi.org/10.1038/nature01323"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-11-18", 
    "datePublishedReg": "2019-11-18", 
    "description": "Since chronic inflammation is associated with the pathogenesis of atherosclerosis, inflammatory cytokines might contribute to the phenotypic modulation of vascular smooth muscle cells (VSMCs). Tumor necrosis factor \u03b1 (TNF\u03b1) facilitated the transformation of contractile VSMCs to the synthetic phenotype, as determined by the expression of marker proteins and a collagen gel contraction assay. Western blot analysis and a cyclooxygenase-2 (COX2) promoter assay revealed that TNF\u03b1 stimulation resulted in the induction of COX2. The overexpression, silencing, or pharmacological inhibition of COX2 significantly affected TNF\u03b1-induced phenotypic conversion, and of the tested prostaglandins, only PGD2 significantly induced phenotypic conversion. ERK was significantly activated by PGD2 stimulation, and the pharmacological inhibition of ERK blocked the PGD2-induced phenotypic conversion of VSMCs. However, antagonists or agonists of PGD2 receptors did not affect VSMC conversion. In contrast, spontaneously dehydrated forms of PGD2, such as PGJ2, \u039412-PGJ2, and 15-d-PGJ2, strongly induced phenotypic conversion. A reporter gene assay showed that TNF\u03b1, PGD2, and 15-d-PGJ2 significantly activated the peroxisome proliferator-responsive element (PPRE) promoter. In addition, the overexpression or silencing of peroxisome proliferator-activated receptor \u03b4 (PPAR\u03b4) significantly influenced 15-d-PGJ2-induced phenotypic conversion. Finally, atherosclerotic neointima formation was significantly suppressed in mice lacking TNF\u03b1. In addition, mice fed celecoxib exhibited complete inhibition of carotid artery ligation-induced neointima formation. This study shows that PGD2 regulates the phenotypic conversion of VSMCs by generating an endogenous ligand of PPAR, and that this leads to neointima formation in occlusive arterial disease.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/s12276-019-0330-3", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1085098", 
        "issn": [
          "1226-3613", 
          "2092-6413"
        ], 
        "name": "Experimental & Molecular Medicine", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "11", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "51"
      }
    ], 
    "keywords": [
      "vascular smooth muscle cells", 
      "smooth muscle cells", 
      "neointima formation", 
      "phenotypic conversion", 
      "pharmacological inhibition", 
      "muscle cells", 
      "peroxisome proliferator-activated receptor \u03b4", 
      "induction of COX2", 
      "occlusive arterial disease", 
      "pathogenesis of atherosclerosis", 
      "necrosis factor \u03b1", 
      "contractile vascular smooth muscle cells", 
      "collagen gel contraction", 
      "cyclooxygenase-2 promoter", 
      "Western blot analysis", 
      "arterial disease", 
      "chronic inflammation", 
      "inflammatory cytokines", 
      "PGD2 receptors", 
      "receptor \u03b4", 
      "prostaglandin D2", 
      "endogenous ligand", 
      "factor \u03b1", 
      "phenotypic modulation", 
      "PGD2", 
      "gel contraction", 
      "TNF\u03b1", 
      "TNF\u03b1 stimulation", 
      "blot analysis", 
      "synthetic phenotype", 
      "\u039412-PGJ2", 
      "inhibition", 
      "complete inhibition", 
      "marker proteins", 
      "stimulation", 
      "element promoter", 
      "phenotypic changes", 
      "ERK", 
      "COX2", 
      "overexpression", 
      "cells", 
      "inflammation", 
      "atherosclerosis", 
      "cytokines", 
      "pathogenesis", 
      "prostaglandins", 
      "agonists", 
      "antagonist", 
      "celecoxib", 
      "PPAR", 
      "mice", 
      "disease", 
      "PGJ2", 
      "reporter gene", 
      "receptors", 
      "contraction", 
      "induction", 
      "phenotype", 
      "expression", 
      "promoter", 
      "modulation", 
      "addition", 
      "protein", 
      "silencing", 
      "D2", 
      "genes", 
      "study", 
      "contrast", 
      "changes", 
      "formation", 
      "analysis", 
      "ligands", 
      "conversion", 
      "form", 
      "transformation"
    ], 
    "name": "Prostaglandin D2 stimulates phenotypic changes in vascular smooth muscle cells", 
    "pagination": "1-10", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1122663772"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/s12276-019-0330-3"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "31735914"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/s12276-019-0330-3", 
      "https://app.dimensions.ai/details/publication/pub.1122663772"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-06-01T22:19", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220601/entities/gbq_results/article/article_804.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/s12276-019-0330-3"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/s12276-019-0330-3'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/s12276-019-0330-3'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/s12276-019-0330-3'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/s12276-019-0330-3'


 

This table displays all metadata directly associated to this object as RDF triples.

271 TRIPLES      22 PREDICATES      121 URIs      111 LITERALS      25 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/s12276-019-0330-3 schema:about N06b4c47c07994d78be126167538e5de3
2 N216e81cf0f0e492a8fead7d44fe6cda7
3 N271efb06d6ae4bcb8105e6c5a785bf5a
4 N298dc7847df74f868fe2875fa12b7c64
5 N2bd89d2ea95640b68f1e5468ddfa6b40
6 N343582d5088847f7b831d7163fc136a8
7 N41952e05b0ab43c8a955b0d7962d3860
8 N4801e9e815cc4d16affa2df6cc2160f3
9 N53596c22e0ab41c1b5a0e9c9a2b58b1f
10 N5c3a01ee593440639350fca042130ba4
11 N64722e6ceb2f412a979a00b63862a114
12 N8eafc5e454784a64b64250b5f1719345
13 Na6ecad897e094317a21bb09b27ad88b9
14 Nc31c792c57374407bd3ac90547a8efa0
15 Nd45fe900d24142b9809e6b0dd9c944d1
16 Nf213129e68e149a0833902f0ce450993
17 Nf67711523d3749719d1e202f68c6352a
18 Nfbf4c9f7e58741aba35e97463282d941
19 anzsrc-for:03
20 anzsrc-for:0304
21 schema:author Nd12496465e4c41b3a8ccf05e95b0017a
22 schema:citation sg:pub.10.1038/358771a0
23 sg:pub.10.1038/nature01323
24 schema:datePublished 2019-11-18
25 schema:datePublishedReg 2019-11-18
26 schema:description Since chronic inflammation is associated with the pathogenesis of atherosclerosis, inflammatory cytokines might contribute to the phenotypic modulation of vascular smooth muscle cells (VSMCs). Tumor necrosis factor α (TNFα) facilitated the transformation of contractile VSMCs to the synthetic phenotype, as determined by the expression of marker proteins and a collagen gel contraction assay. Western blot analysis and a cyclooxygenase-2 (COX2) promoter assay revealed that TNFα stimulation resulted in the induction of COX2. The overexpression, silencing, or pharmacological inhibition of COX2 significantly affected TNFα-induced phenotypic conversion, and of the tested prostaglandins, only PGD2 significantly induced phenotypic conversion. ERK was significantly activated by PGD2 stimulation, and the pharmacological inhibition of ERK blocked the PGD2-induced phenotypic conversion of VSMCs. However, antagonists or agonists of PGD2 receptors did not affect VSMC conversion. In contrast, spontaneously dehydrated forms of PGD2, such as PGJ2, Δ12-PGJ2, and 15-d-PGJ2, strongly induced phenotypic conversion. A reporter gene assay showed that TNFα, PGD2, and 15-d-PGJ2 significantly activated the peroxisome proliferator-responsive element (PPRE) promoter. In addition, the overexpression or silencing of peroxisome proliferator-activated receptor δ (PPARδ) significantly influenced 15-d-PGJ2-induced phenotypic conversion. Finally, atherosclerotic neointima formation was significantly suppressed in mice lacking TNFα. In addition, mice fed celecoxib exhibited complete inhibition of carotid artery ligation-induced neointima formation. This study shows that PGD2 regulates the phenotypic conversion of VSMCs by generating an endogenous ligand of PPAR, and that this leads to neointima formation in occlusive arterial disease.
27 schema:genre article
28 schema:inLanguage en
29 schema:isAccessibleForFree true
30 schema:isPartOf N8eec93cd72b248b29de3134c4b84474c
31 Nc38df18857b540ffaf16610dae71f4d8
32 sg:journal.1085098
33 schema:keywords COX2
34 D2
35 ERK
36 PGD2
37 PGD2 receptors
38 PGJ2
39 PPAR
40 TNFα
41 TNFα stimulation
42 Western blot analysis
43 addition
44 agonists
45 analysis
46 antagonist
47 arterial disease
48 atherosclerosis
49 blot analysis
50 celecoxib
51 cells
52 changes
53 chronic inflammation
54 collagen gel contraction
55 complete inhibition
56 contractile vascular smooth muscle cells
57 contraction
58 contrast
59 conversion
60 cyclooxygenase-2 promoter
61 cytokines
62 disease
63 element promoter
64 endogenous ligand
65 expression
66 factor α
67 form
68 formation
69 gel contraction
70 genes
71 induction
72 induction of COX2
73 inflammation
74 inflammatory cytokines
75 inhibition
76 ligands
77 marker proteins
78 mice
79 modulation
80 muscle cells
81 necrosis factor α
82 neointima formation
83 occlusive arterial disease
84 overexpression
85 pathogenesis
86 pathogenesis of atherosclerosis
87 peroxisome proliferator-activated receptor δ
88 pharmacological inhibition
89 phenotype
90 phenotypic changes
91 phenotypic conversion
92 phenotypic modulation
93 promoter
94 prostaglandin D2
95 prostaglandins
96 protein
97 receptor δ
98 receptors
99 reporter gene
100 silencing
101 smooth muscle cells
102 stimulation
103 study
104 synthetic phenotype
105 transformation
106 vascular smooth muscle cells
107 Δ12-PGJ2
108 schema:name Prostaglandin D2 stimulates phenotypic changes in vascular smooth muscle cells
109 schema:pagination 1-10
110 schema:productId N3fde75afc6e6476cbc0770d8feb4aae7
111 N612f7739b5464a1586b8b5dd6e0e8b0b
112 N8230ed6b6f4f4253a31aac5c243b4da0
113 schema:sameAs https://app.dimensions.ai/details/publication/pub.1122663772
114 https://doi.org/10.1038/s12276-019-0330-3
115 schema:sdDatePublished 2022-06-01T22:19
116 schema:sdLicense https://scigraph.springernature.com/explorer/license/
117 schema:sdPublisher Nb07e493986c844b0b25e1591543dd180
118 schema:url https://doi.org/10.1038/s12276-019-0330-3
119 sgo:license sg:explorer/license/
120 sgo:sdDataset articles
121 rdf:type schema:ScholarlyArticle
122 N06b4c47c07994d78be126167538e5de3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Mice, Mutant Strains
124 rdf:type schema:DefinedTerm
125 N13813cd5e0bb44e181155d1e6d9eb8e1 rdf:first sg:person.01372533376.74
126 rdf:rest N8979934b78504c7ebbcd9c17e60bfd8a
127 N216e81cf0f0e492a8fead7d44fe6cda7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Cyclooxygenase 2
129 rdf:type schema:DefinedTerm
130 N271efb06d6ae4bcb8105e6c5a785bf5a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Mice
132 rdf:type schema:DefinedTerm
133 N298dc7847df74f868fe2875fa12b7c64 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Rats
135 rdf:type schema:DefinedTerm
136 N2bd89d2ea95640b68f1e5468ddfa6b40 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Immunohistochemistry
138 rdf:type schema:DefinedTerm
139 N343582d5088847f7b831d7163fc136a8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name PPAR gamma
141 rdf:type schema:DefinedTerm
142 N3e847d902cba42938a4992818d840ec2 rdf:first sg:person.01032567265.78
143 rdf:rest Nc0bda7e36ca84788a8daf0f3f803ced8
144 N3fde75afc6e6476cbc0770d8feb4aae7 schema:name dimensions_id
145 schema:value pub.1122663772
146 rdf:type schema:PropertyValue
147 N41952e05b0ab43c8a955b0d7962d3860 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Blotting, Western
149 rdf:type schema:DefinedTerm
150 N4801e9e815cc4d16affa2df6cc2160f3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Tumor Necrosis Factor-alpha
152 rdf:type schema:DefinedTerm
153 N4e63d7a4a27f42a2b2f50ece2b0c1ee6 rdf:first sg:person.0712676025.34
154 rdf:rest N3e847d902cba42938a4992818d840ec2
155 N53596c22e0ab41c1b5a0e9c9a2b58b1f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Lentivirus
157 rdf:type schema:DefinedTerm
158 N5c3a01ee593440639350fca042130ba4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Signal Transduction
160 rdf:type schema:DefinedTerm
161 N612f7739b5464a1586b8b5dd6e0e8b0b schema:name doi
162 schema:value 10.1038/s12276-019-0330-3
163 rdf:type schema:PropertyValue
164 N64722e6ceb2f412a979a00b63862a114 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
165 schema:name Myocytes, Smooth Muscle
166 rdf:type schema:DefinedTerm
167 N8230ed6b6f4f4253a31aac5c243b4da0 schema:name pubmed_id
168 schema:value 31735914
169 rdf:type schema:PropertyValue
170 N8979934b78504c7ebbcd9c17e60bfd8a rdf:first sg:person.01324754010.02
171 rdf:rest N4e63d7a4a27f42a2b2f50ece2b0c1ee6
172 N8eafc5e454784a64b64250b5f1719345 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Cells, Cultured
174 rdf:type schema:DefinedTerm
175 N8eec93cd72b248b29de3134c4b84474c schema:volumeNumber 51
176 rdf:type schema:PublicationVolume
177 Na6ecad897e094317a21bb09b27ad88b9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
178 schema:name Male
179 rdf:type schema:DefinedTerm
180 Nb07e493986c844b0b25e1591543dd180 schema:name Springer Nature - SN SciGraph project
181 rdf:type schema:Organization
182 Nc0bda7e36ca84788a8daf0f3f803ced8 rdf:first sg:person.015416324124.64
183 rdf:rest Nf6c2185f37ed44f2883b1276edce8e74
184 Nc31c792c57374407bd3ac90547a8efa0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
185 schema:name Muscle, Smooth, Vascular
186 rdf:type schema:DefinedTerm
187 Nc38df18857b540ffaf16610dae71f4d8 schema:issueNumber 11
188 rdf:type schema:PublicationIssue
189 Nd12496465e4c41b3a8ccf05e95b0017a rdf:first sg:person.0725005515.87
190 rdf:rest Nd766c4afd289498a871e23e8156ca546
191 Nd45fe900d24142b9809e6b0dd9c944d1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
192 schema:name Rats, Sprague-Dawley
193 rdf:type schema:DefinedTerm
194 Nd766c4afd289498a871e23e8156ca546 rdf:first sg:person.0713276127.36
195 rdf:rest N13813cd5e0bb44e181155d1e6d9eb8e1
196 Nf213129e68e149a0833902f0ce450993 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
197 schema:name Prostaglandin D2
198 rdf:type schema:DefinedTerm
199 Nf67711523d3749719d1e202f68c6352a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
200 schema:name Animals
201 rdf:type schema:DefinedTerm
202 Nf6c2185f37ed44f2883b1276edce8e74 rdf:first sg:person.01113214531.31
203 rdf:rest rdf:nil
204 Nfbf4c9f7e58741aba35e97463282d941 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
205 schema:name Phenotype
206 rdf:type schema:DefinedTerm
207 anzsrc-for:03 schema:inDefinedTermSet anzsrc-for:
208 schema:name Chemical Sciences
209 rdf:type schema:DefinedTerm
210 anzsrc-for:0304 schema:inDefinedTermSet anzsrc-for:
211 schema:name Medicinal and Biomolecular Chemistry
212 rdf:type schema:DefinedTerm
213 sg:journal.1085098 schema:issn 1226-3613
214 2092-6413
215 schema:name Experimental & Molecular Medicine
216 schema:publisher Springer Nature
217 rdf:type schema:Periodical
218 sg:person.01032567265.78 schema:affiliation grid-institutes:grid.412588.2
219 schema:familyName Song
220 schema:givenName Sang Heon
221 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01032567265.78
222 rdf:type schema:Person
223 sg:person.01113214531.31 schema:affiliation grid-institutes:grid.262229.f
224 schema:familyName Bae
225 schema:givenName Sun Sik
226 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01113214531.31
227 rdf:type schema:Person
228 sg:person.01324754010.02 schema:affiliation grid-institutes:grid.262229.f
229 schema:familyName Jin
230 schema:givenName Seo Yeon
231 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01324754010.02
232 rdf:type schema:Person
233 sg:person.01372533376.74 schema:affiliation grid-institutes:grid.262229.f
234 schema:familyName Ha
235 schema:givenName Jung Min
236 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01372533376.74
237 rdf:type schema:Person
238 sg:person.015416324124.64 schema:affiliation grid-institutes:grid.262229.f
239 schema:familyName Kim
240 schema:givenName Chi Dae
241 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015416324124.64
242 rdf:type schema:Person
243 sg:person.0712676025.34 schema:affiliation grid-institutes:grid.412588.2
244 schema:familyName Ha
245 schema:givenName Hong Koo
246 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0712676025.34
247 rdf:type schema:Person
248 sg:person.0713276127.36 schema:affiliation grid-institutes:grid.262229.f
249 schema:familyName Yun
250 schema:givenName Sung Ji
251 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0713276127.36
252 rdf:type schema:Person
253 sg:person.0725005515.87 schema:affiliation grid-institutes:grid.262229.f
254 schema:familyName Lee
255 schema:givenName Hye Sun
256 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0725005515.87
257 rdf:type schema:Person
258 sg:pub.10.1038/358771a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007692609
259 https://doi.org/10.1038/358771a0
260 rdf:type schema:CreativeWork
261 sg:pub.10.1038/nature01323 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001371417
262 https://doi.org/10.1038/nature01323
263 rdf:type schema:CreativeWork
264 grid-institutes:grid.262229.f schema:alternateName Gene and Cell Therapy Center for Vessel-Associated Disease, Medical Research Institute, and Department of Pharmacology, Pusan National University School of Medicine, 50612, Gyungnam, Republic of Korea
265 schema:name Gene and Cell Therapy Center for Vessel-Associated Disease, Medical Research Institute, and Department of Pharmacology, Pusan National University School of Medicine, 50612, Gyungnam, Republic of Korea
266 rdf:type schema:Organization
267 grid-institutes:grid.412588.2 schema:alternateName Department of Internal Medicine, Pusan National University Hospital, 49241, Busan, Republic of Korea
268 Department of Urology, Pusan National University Hospital, 49241, Busan, Republic of Korea
269 schema:name Department of Internal Medicine, Pusan National University Hospital, 49241, Busan, Republic of Korea
270 Department of Urology, Pusan National University Hospital, 49241, Busan, Republic of Korea
271 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...